1 Frei E, 3rd: Clinical cancer research: an embattled species. Cancer 1982;50:1979-1992.
2 Lee HS, Kim WH, Kwak Y, Koh J, Bae JM, Kim KM, Chang MS, Han HS, Kim JM, Kim HW, Chang HK, Choi YH, Park JY, Gu MJ, Lhee MJ, Kim JY, Kim HS, Cho MY, Gastrointestinal Pathology Study Group of Korean Society of P, Molecular Pathology Study Group of Korean Society of P: Molecular Testing for Gastrointestinal Cancer. J Pathol Transl Med 2017;51:103-121.
3 Li B, Liu HY, Guo SH, Sun P, Gong FM, Jia BQ: Detection of microsatellite instability in gastric cancer and dysplasia tissues. Int J Clin Exp Med 2015;8:21442-21447.
4 Wu H, Wang W, Tong S, Wu C: Nucleostemin regulates proliferation and migration of gastric cancer and correlates with its malignancy. Int J Clin Exp Med 2015;8:17634-17643.
5 Peyrou M, Bourgoin L, Foti M: PTEN in liver diseases and cancer. World J Gastroenterol 2010;16:4627-4633.
6 Perez-Ramirez C, Canadas-Garre M, Molina MA, Faus-Dader MJ, Calleja-Hernandez MA: PTEN and PI3K/AKT in non-small-cell lung cancer. Pharmacogenomics 2015;16:1843-1862.
7 Gupta A, Dey CS: PTEN and SHIP2 regulates PI3K/Akt pathway through focal adhesion kinase. Mol Cell Endocrinol 2009;309:55-62.
8 Li A, Qiu M, Zhou H, Wang T, Guo W: PTEN, Insulin Resistance and Cancer. Curr Pharm Des 2017;23:3667-3676.
9 Fei G, Ebert MP, Mawrin C, Leodolter A, Schmidt N, Dietzmann K, Malfertheiner P: Reduced PTEN expression in gastric cancer and in the gastric mucosa of gastric cancer relatives. Eur J Gastroenterol Hepatol 2002;14:297-303.
10 Zheng HC, Li YL, Sun JM, Yang XF, Li XH, Jiang WG, Zhang YC, Xin Y: Growth, invasion, metastasis, differentiation, angiogenesis and apoptosis of gastric cancer regulated by expression of PTEN encoding products. World J Gastroenterol 2003;9:1662-1666.
11 Giri D, Ittmann M: Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma. Hum Pathol 1999;30:419-424.
12 Zheng T, Meng X, Wang J, Chen X, Yin D, Liang Y, Song X, Pan S, Jiang H, Liu L: PTEN- and p53-mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice. J Cell Biochem 2010;111:218-228.
13 Zhang LL, Liu J, Lei S, Zhang J, Zhou W, Yu HG: PTEN inhibits the invasion and metastasis of gastric cancer via downregulation of FAK expression. Cell Signal 2014;26:1011-1020.
14 Pei YF, Tao R, Li JF, Su LP, Yu BQ, Wu XY, Yan M, Gu QL, Zhu ZG, Liu BY: TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression. Oncotarget 2016;7:31322-31335.
15 Song S, Wang B, Zhang X, Hao L, Hu X, Li Z, Sun S: Long-Term Diabetes Mellitus Is Associated with an Increased Risk of Pancreatic Cancer: A Meta-Analysis. PLoS One 2015;10:e0134321.
16 Knight A, Askling J, Ekbom A: Cancer incidence in a population-based cohort of patients with Wegener's granulomatosis. Int J Cancer 2002;100:82-85.
17 Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM: Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005;293:194-202.
18 Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VWS, Wu JCY, Chan FKL, Sung JJY, Kaplan GG, Ng SC: Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology 2017;153:420-429.
19 Bessede E, Staedel C, Acuna Amador LA, Nguyen PH, Chambonnier L, Hatakeyama M, Belleannee G, Megraud F, Varon C: Helicobacter pylori generates cells with cancer stem cell properties via epithelial-mesenchymal transition-like changes. Oncogene 2014;33:4123-4131.
20 Zhang B, Zhang X, Jin M, Hu L, Zang M, Qiu W, Wang S, Liu B, Liu S, Guo D: CagA increases DNA methylation and decreases PTEN expression in human gastric cancer. Mol Med Rep 2019;19:309-319.
21 Wahdan-Alaswad RS, Cochrane DR, Spoelstra NS, Howe EN, Edgerton SM, Anderson SM, Thor AD, Richer JK: Metformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193b. Horm Cancer 2014;5:374-389.
22 Luo M, Tan X, Mu L, Luo Y, Li R, Deng X, Chen N, Ren M, Li Y, Wang L, Wu J, Wan Q: MiRNA-21 mediates the antiangiogenic activity of metformin through targeting PTEN and SMAD7 expression and PI3K/AKT pathway. Sci Rep 2017;7:43427.
23 Yin L, Cai WJ, Chang XY, Li J, Zhu LY, Su XH, Yu XF, Sun K: Analysis of PTEN expression and promoter methylation in Uyghur patients with mild type 2 diabetes mellitus. Medicine (Baltimore) 2018;97:e13513.
24 Ataseven H, Demir M, Gen R: Effect of sequential treatment as a first-line therapy for Helicobacter pylori eradication in patients with diabetes mellitus. South Med J 2010;103:988-992.
25 Hosseininasab Nodoushan SA, Nabavi A: The Interaction of Helicobacter pylori Infection and Type 2 Diabetes Mellitus. Adv Biomed Res 2019;8:15.
26 Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE: Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001;108:1167-1174.
27 Decensi A, Puntoni M, Goodwin P, Cazzaniga M, Gennari A, Bonanni B, Gandini S: Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev Res (Phila) 2010;3:1451-1461.
28 Tseng CH: Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes. Liver Int 2018;38:2018-2027.
29 Kato K, Gong J, Iwama H, Kitanaka A, Tani J, Miyoshi H, Nomura K, Mimura S, Kobayashi M, Aritomo Y, Kobara H, Mori H, Himoto T, Okano K, Suzuki Y, Murao K, Masaki T: The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo. Mol Cancer Ther 2012;11:549-560.
30 Nguyen PH, Giraud J, Chambonnier L, Dubus P, Wittkop L, Belleannee G, Collet D, Soubeyran I, Evrard S, Rousseau B, Senant-Dugot N, Megraud F, Mazurier F, Varon C: Characterization of Biomarkers of Tumorigenic and Chemoresistant Cancer Stem Cells in Human Gastric Carcinoma. Clin Cancer Res 2017;23:1586-1597.
31 Fox JG, Li X, Cahill RJ, Andrutis K, Rustgi AK, Odze R, Wang TC: Hypertrophic gastropathy in Helicobacter felis-infected wild-type C57BL/6 mice and p53 hemizygous transgenic mice. Gastroenterology 1996;110:155-166.
32 Keniry M, Parsons R: The role of PTEN signaling perturbations in cancer and in targeted therapy. Oncogene 2008;27:5477-5485.
33 Simpson L, Parsons R: PTEN: life as a tumor suppressor. Exp Cell Res 2001;264:29-41.
34 Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, Cho KH, Aiba S, Brocker EB, LeBoit PE, Pinkel D, Bastian BC: Distinct sets of genetic alterations in melanoma. N Engl J Med 2005;353:2135-2147.
35 Lahtz C, Stranzenbach R, Fiedler E, Helmbold P, Dammann RH: Methylation of PTEN as a prognostic factor in malignant melanoma of the skin. J Invest Dermatol 2010;130:620-622.
36 Noto JM, Peek RM, Jr.: Helicobacter pylori: an overview. Methods Mol Biol 2012;921:7-10.
37 Elzouki AN, Buhjab SI, Alkialani A, Habel S, Sasco AJ: Gastric cancer and Helicobacter pylori infection in the eastern Libya: a descriptive epidemiological study. Arab J Gastroenterol 2012;13:85-88.
38 Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, Massone A, Papini E, Xiang Z, Figura N, et al.: Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A 1993;90:5791-5795.
39 Tummuru MK, Cover TL, Blaser MJ: Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun 1993;61:1799-1809.
40 Hatakeyama M: SagA of CagA in Helicobacter pylori pathogenesis. Curr Opin Microbiol 2008;11:30-37.
41 Backert S, Tegtmeyer N, Selbach M: The versatility of Helicobacter pylori CagA effector protein functions: The master key hypothesis. Helicobacter 2010;15:163-176.
42 Tabassam FH, Graham DY, Yamaoka Y: Helicobacter pylori activate epidermal growth factor receptor- and phosphatidylinositol 3-OH kinase-dependent Akt and glycogen synthase kinase 3beta phosphorylation. Cell Microbiol 2009;11:70-82.
43 Yoon JH, Seo HS, Choi SS, Chae HS, Choi WS, Kim O, Ashktorab H, Smoot DT, Nam SW, Lee JY, Park WS: Gastrokine 1 inhibits the carcinogenic potentials of Helicobacter pylori CagA. Carcinogenesis 2014;35:2619-2629.
44 Zaidi SF, Refaat A, Zhou Y, Sualeh Muhammad J, Shin MS, Saiki I, Sakurai H, Sugiyama T: Helicobacter pylori Induces Serine Phosphorylation of EGFR via Novel TAK1-p38 Activation Pathway in an HB-EGF-Independent Manner. Helicobacter 2015;20:381-389.
45 Clark AS, West K, Streicher S, Dennis PA: Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Mol Cancer Ther 2002;1:707-717.
46 Kraus AC, Ferber I, Bachmann SO, Specht H, Wimmel A, Gross MW, Schlegel J, Suske G, Schuermann M: In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways. Oncogene 2002;21:8683-8695.
47 Lan KH, Lee WP, Wang YS, Liao SX, Lan KH: Helicobacter pylori CagA protein activates Akt and attenuates chemotherapeutics-induced apoptosis in gastric cancer cells. Oncotarget 2017;8:113460-113471.
48 Su D, Zhang CL, Gao YC, Liu XY, Li CP, Huangfu J, Xiao R: Gene Expression and Correlation of Pten and Fabp4 in Liver, Muscle, and Adipose Tissues of Type 2 Diabetes Rats. Med Sci Monit 2015;21:3616-3621.
49 Zhu L, Zhao S, Liu S, Liu Q, Li F, Hao J: PTEN Regulates Renal Extracellular Matrix Deposit via Increased CTGF in Diabetes Mellitus. J Cell Biochem 2016;117:1187-1198.
50 Li YY, Xiao R, Li CP, Huangfu J, Mao JF: Increased plasma levels of FABP4 and PTEN is associated with more severe insulin resistance in women with gestational diabetes mellitus. Med Sci Monit 2015;21:426-431.